The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice

Toxicology Letters

Volumn 128, Issue 1-3, 2002, Pages 169-175

  Eybl, Vladislav ^a   Kotyzová, Dana ^a   Kolek, Metodíj ^a   Koutenský, Jaroslav ^a   Nielsen, Peter ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Deferiprone; Deferoxamine; Iron chelators; TMH ferrocene

Indexed keywords

CATALASE; DEFERIPRONE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; FERROCENE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG EFFECT; ENZYME REGULATION; HEART; IRON OVERLOAD; KIDNEY; LIPID PEROXIDATION; LIVER LEVEL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE LEVEL;

ANIMALS; CATALASE; DEFEROXAMINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IRON CHELATING AGENTS; IRON OVERLOAD; IRON, DIETARY; LIPID PEROXIDES; LIVER; MALE; MICE; PYRIDONES;

ANIMALIA;

EID: 0037051144     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00541-0     Document Type: Article

References (15)

1. Catalase
2. Efficacy and possible adverse effects of the oral iron chelator 1,2 dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major
3. Effect of chelators on kadmium induced lipid peroxidation and GSH level in the liver tissue of mice
4. An improved coupled test procedure for glutathione peroxidase (EC 1.11.1.9.) in blood
5. Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1)
6. Iron overload toxicity and new therapeutic strategies with the orally effective chelating drug deferiprone (L1)
7. Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in mice
8. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test
9. Metabolism of iron from (3,5,5-trimethylhexanoyl) ferrocene in rats
10. Non-transferrin-bound-iron in serum and low-molecular-weight-iron in the liver of dietary iron-loaded rats
11. Iron chelating therapy and the treatment of thalassemia
12. Interaction of L1-deferiprone with Cu(II) and U(VI) ions. Chemical characterization of solid phases and possible clinical applications
13. The therapeutic potential of iron chelators
14. Estimation of total, protein-bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent
15. Lipid peroxidation and glutathione levels after cortical injection of ferric chloride in rats: Effect of trimetazidine and deferoxamine